Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Reports Q1 Loss of $0.63/Share

May 8, 2019 7:40 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.63), versus ($0.65) reported last year.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More